These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5611109)

  • 1. [The association of raubasine and ergot derivatives in therapy of peripheral vascular diseases].
    Sforza M; Perelli-Ercolini M
    Minerva Cardioangiol; 1967 Oct; 15(10):655-8. PubMed ID: 5611109
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical contribution to the therapy of senile vascular diseases].
    Ceino A; Vizioli A
    Clin Ter; 1966 May; 37(3):242-50. PubMed ID: 5962630
    [No Abstract]   [Full Text] [Related]  

  • 3. [Defluine (an association of raubasine and ergot derivatives) in the treatment of senile cerebral vascular diseases of a sclerotic nature].
    Turri C
    Minerva Med; 1970 Aug; 61(65):3466-76. PubMed ID: 5451093
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
    Martínez-López JM; Calvo-Fernández R; Garrido-Toro A; Sánchez-Cañaveral F
    Angiologia; 1973; 25(4):195-8. PubMed ID: 4717702
    [No Abstract]   [Full Text] [Related]  

  • 5. [Raubasine in arterial pathology of the extremities].
    Perrin M
    Lyon Med; 1965 May; 213(21):1585-90. PubMed ID: 5828799
    [No Abstract]   [Full Text] [Related]  

  • 6. [Raubasine in combination with ergot alkaloid derivatives in the therapy of closed injuries of the brain].
    Stoppani L
    Arch Sci Med (Torino); 1965 Nov; 120(5):431-9. PubMed ID: 4956319
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plethysmographic studies in Raynaud's phenomenon. Results of raubasin-ergotamine treatments].
    Neitzert A; Goebel KM
    Schweiz Med Wochenschr; 1974 Nov; 104(44):1595-6. PubMed ID: 4424617
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacodynamic observations on metronidazole therapy. Side effects in endocrine, metabolic and auto-immune disorders. 3. Anti-ischemic and anti-inflammatory action in peripheral vascular disorders.
    Taylor JA
    Proc West Pharmacol Soc; 1966; 9():37-9. PubMed ID: 4381145
    [No Abstract]   [Full Text] [Related]  

  • 9. [Our experience in the treatment of peripheral vascular diseases with raubasine].
    Vercellio G; Costantini S; Giulini S
    Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the association of raubasine and dihydroergocristine in the aged patient with vascular disease].
    Sauter R
    Lille Med; 1971; 17():Suppl 3:551-8. PubMed ID: 5005074
    [No Abstract]   [Full Text] [Related]  

  • 11. [Peptide alkaloids of spurred rye and their semisynthetic derivatives. III. Ergot in therapeutics].
    Mercier C
    J Pharm Belg; 1982; 37(4):289-98. PubMed ID: 6754905
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of disodium flavodate in circulatory insufficiencies].
    Roussel J
    Phlebologie; 1972; 25(1):83-8. PubMed ID: 5044962
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of some vascular diseases with the use of oxyphenyl-oxybutylamino-ethanol].
    Berezovsky M; Berstein S
    Prensa Med Argent; 1966 Sep; 53(36):1964-71. PubMed ID: 4384691
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical action in vascular pathology of the limbs, of an original association of raubasine and 711 SE].
    Bouret G; Coget JM; Merlen JF; Warembourg H
    Lille Med; 1970 Mar; 15(3 Suppl 2):440-3. PubMed ID: 5421804
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of varicose leg ulcers with DRA 363].
    Dorobisz T; Jaworski Z
    Wiad Lek; 1969 Mar; 22(6):581-8. PubMed ID: 5788876
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent peroral therapy of the varicose symptom complex].
    Matanić V
    Z Haut Geschlechtskr; 1969 Sep; 44(18):735-41. PubMed ID: 5393604
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical observations with a new combination of peripheral vasodilating agents].
    Dameno G
    Minerva Cardioangiol; 1967 Mar; 15(5):357-9. PubMed ID: 5603842
    [No Abstract]   [Full Text] [Related]  

  • 18. [Skin diseases due to chronic venous insufficiency of the lower limbs and their treatment].
    Ricciardi L
    Arch Ital Dermatol Venereol Sessuol; 1971; 37(1):31-7. PubMed ID: 5169777
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rheocencephalographic changes in cerebral vascular diseases in the aged treated with the association of Raubasine and ergot alkaloids].
    Pasoli CA; Mansoldo G
    Minerva Cardioangiol; 1970 Apr; 18(4):267-71. PubMed ID: 5423416
    [No Abstract]   [Full Text] [Related]  

  • 20. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
    D'Ayala Valva G
    Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.